Samantha Barichievy
Senior Director Reagents & Assays Sweden, Astrazeneca
Sam Barichievy is a scientific and strategic leader in drug discovery whose work sits at the intersection of reagents and assays, portfolio leadership, data science translation, and applied AI. In AstraZeneca, Sam leads the Reagents & Assays Sweden department alongside broader BioPharma therapy area activities, with a strong focus on accelerating decision-making, de-risking early discovery, and improving portfolio outcomes through data-driven operating models. A consistent theme in Sam’s leadership is the ability to connect scientific depth with enterprise execution. This includes driving adoption of advanced cell models as a default approach for discovery workflows, building Power BI-based portfolio metrics for real-time visibility, and helping shape cross-functional delivery around challenging and novel targets. Sam also partners closely across functions to improve data mapping, process design, and operational clarity. Sam is particularly recognised for her strengths in AI-focuse
Events Samantha Barichievy has spoken at
- ELRIG Drug Discovery 2026 14 October 2026 – 15 October 2026